Physician profile
Frederick Asher
NPI 1790714806
$2,766.88
in general payments reported to CMS, 2019-2025
19 companies · $435 in 2025
The $435 reported for 2025 was more than what 88% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $311 · 2020: $203 · 2021: $327 · 2022: $385 · 2023: $539 · 2024: $566 · 2025: $435.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,541.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,540.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $513.30 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $506.65 | 2019-2024 | Xarelto |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $338.62 | 2019-2025 | Xifaxan |
| Abbvie INC. | $263.58 | 2022-2025 | Teflaro, Avycaz |
| Novartis Pharmaceuticals Corporation | $192.76 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $189.54 | 2019-2023 | Camzyos, Eliquis |
| Alexion Pharmaceuticals, INC. | $175.77 | 2022-2024 | Ultomiris |
| Merck Sharp & Dohme LLC | $115.10 | 2020-2022 | |
| Mallinckrodt Hospital Products INC. | $109.26 | 2024-2025 | Terlivaz |
| Astrazeneca Pharmaceuticals Lp | $98.63 | 2020-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $52.06 | 2021-2023 | Gattex |
| Smith+Nephew, INC. | $49.42 | 2023-2025 | Collagenase Santyl |
| Astellas Pharma US INC | $44.55 | 2023 | Cresemba |
| Aimmune Therapeutics, INC. | $30.60 | 2025 | Vowst |
| Stryker Corporation | $30.12 | 2024 | Procuity |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $16.63 | 2019 | |
| Gilead Sciences, INC. | $14.96 | 2021 | |
| Scpharmaceuticals INC. | $13.54 | 2024 | |
| Allergan, INC. | $11.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Asher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.